Matitiahu Lifshitz

Carbamate and organophosphate poisoning in young children

OBJECTIVE Retrospective evaluation of the clinical course of carbamate and organophosphate poisoning in young children. DESIGN The records of 36 children intoxicated with carbamate and 16 children intoxicated with organophosphate (age range: 2 to 8 years, median: 2.8 years) were examined retrospectively. The carbamate agents were identified as methomyl or aldicarb, and the organophosphate as parathion, fenthion, malathion, and diazinon. The causes of poisoning were accidental ingestion in 46 children and inhalation in six children. CLINICAL SETTING Pediatric Intensive Care Unit of a teaching hospital. INTERVENTIONS Gastric lavage was performed, and activated charcoal was administered to all children who had ingested poisonous pesticides. Atropine sulphate was administered intravenously in repeated doses to all children with bradycardia, diarrhea, salivation, and miosis. Obidoxime chloride was administered to patients with organophosphate poisoning and to those in whom the ingested material was unidentified on admission. RESULTS Predominant symptoms were related to central nervous system depression and severe hypotonia. Other clinical signs such as miosis, diarrhea, salivation, bradycardia, and fasciculation were less frequent, while tearing and diaphoresis were not observed. Pulmonary edema developed in six patients with organophosphte poisoning. Three children required mechanical ventilation for several hours. One child (organophosphate poisoning) died shortly after arrival at the emergency department. All other children recovered completely. CONCLUSION Based on a relatively large group of young pediatric patients with carbamate and organophosphate poisoning, it is concluded that the clinical presentation differed from those described in adults. Absence of classic muscarinic effects does not exclude the possibility of cholinesterase inhibitor agents poisoning in young children with central nervous system depression.

Interleukin-12 Receptor β1 Deficiency Presenting as Recurrent Salmonella Infection

We describe a child with interleukin-12 receptor beta1 (IL-12Rbeta1) deficiency caused by a homozygous IL12RB1 large deletion who presented at the age of 1 year with recurrent, often asymptomatic episodes of bacteremia caused by group D Salmonella species. No mycobacterial disease or other unusual infection was present. The episodes of salmonellosis were caused by an identical serovar during a period of 18 months. This is the first case of inherited IL-12Rbeta1 deficiency diagnosed after isolated, recurrent salmonellosis.

Signs and symptoms of carbamazepine overdose in young children.

Objective To examine common signs and symptoms of mild to moderate carbamazepine (CBZ) overdose in young children. Methods The medical records of previously healthy children admitted to the pediatric departments for acute accidental CBZ poisoning during the years 1993–1998 were evaluated retrospectively. Information was retrieved on serum CBZ levels, signs and symptoms on admission and during hospitalization, ECG findings, and chemical laboratory test. Results There were 14 exposed children all under the age of 5 years. These children accidentally took CBZ prescribed for a family member. The diagnosis of CBZ poisoning in seven children was unknown on admission because of inadequate history and was revealed only on toxicology screen. Nystagmus and drowsiness occurred in 8 of the 14 children, nystagmus and ataxia in 4 children, and drowsiness and tachycardia in another 2 children. The peak CBZ serum levels in these children ranged from 18 μg/ml to 32 μg/ml, mean + SD; 25 μg/ml + 4.64 μg/ml (therapeutic range: 5–10 μg/ml). Conclusion Based on a certain group of young pediatric patients with mild to moderate CBZ poisoning, it is concluded that, nystagmus is the most common sign of this overdose. Other common signs are drowsiness and ataxia. The presence of nystagmus and CNS depression of unknown etiology, in a young child should suggest the possibility of CBZ toxicity.

Disseminated intravascular coagulation after cerastes vipera envenomation in a 3-year-old child: a case report.

This study presents a case of severe disseminated intravascular coagulation (DIC) in a 3-year-old child following envenomation by the snake, Cerastes vipera. A literature search revealed very few similar cases. We describe a child who was bitten in his left foot by a snake identified as a C. vipera. Initial symptoms were relatively benign. Local signs included a hemorrhagic vesicle at the site of the bite with marked swelling of the entire leg. Twenty-four hours later, the child developed severe bleeding due to DIC, which lasted 5 days and required repeated administration of blood and blood products and total exchange transfusion. The patient was discharged from the hospital after 7 days in good condition. To the best of our knowledge, severe DIC following envenomation by a C. vipera has not been previously described in the literature. Treatment was essentially supportive. The case report indicates that a specific antivenin against this snakes venom should be made available in our area.

Monitoring phenytoin therapy using citric acid-stimulated saliva in infants and children.

Two factors have limited the use of saliva in monitoring phenytoin therapy: availability of adequate volume of clear saliva and lack of a sensitive phenytoin assay. The applicability of citric acid-stimulated saliva and of a sensitive analytical assay (fluorescence polarization immunoassay, “TDx” Abbott) was evaluated in this study. Phenytoin was measured in paired plasma-saliva specimens from epileptic children during the long-term or the initial phase of phenytoin therapy. Analysis was carried out in plasma and in the clear supernatant of saliva (following centrifugation). Pooled-estimate SD of the analytical assay variability was 0.175 μg/ml for plasma total phenytoin, 0.063 for plasma free phenytoin, and 0.009 for saliva phenytoin. Recovery measurements of phenytoin spiked into saliva samples gave a coefficient of variation of less than 5%. Correlations between saliva and total plasma phenytoin levels and between saliva and free plasma phenytoin levels were strong and highly significant (r = 0.99, p < 0.01). The percentage of temporal fluctuation (as determined by saliva phenytoin profiles) during 10–24 h ranged between 25.5–177 (mean, 58.3; SD, 47.3). Ratios of plasma total phenytoin/saliva phenytoin and of plasma free phenytoin/saliva phenytoin levels were 9.54 ± 1.05 and 0.71 ± 0.09, respectively. Dialysis experiments showed no binding of phenytoin to saliva supernatant. The greater saliva phenytoin concentrations as compared to plasma free phenytoin concentrations could be due to active transport of phenytoin from plasma to saliva. Measurement of phenytoin in citric acid-stimulated saliva by fluorescent polarization immunoassay is a reliable, noninvasive, and convenient method for monitoring phenytoin therapy in children.

The Incidence and Nature of Adverse Reactions during Intravenous Acetylcysteine Therapy for Acetaminophen Overdose

Objective: To determine the incidence of adverse drug reactions in patients with acetaminophen overdose following administration of intravenous acetylcysteine, and to evaluate the cost-benefit ratio of intravenous compared with oral acetylcysteine therapy. Methods: The incidence of adverse drug reactions to intravenous acetylcysteine therapy was studied retrospectively in all patients with acetaminophen overdose who were admitted to Soroka University Medical Center, Beer-Sheva, Israel, from 1994 to 1998. Data were obtained from hospital records. All patients were treated with a 20-hour intravenous regimen according to the Prescott protocol. Special attention was paid to the clinical manifestations of adverse reactions, time of onset, and history of patient allergy and asthma. Cost of therapy (drug prices, hospital per diems) for intravenous versus oral acetylcysteine administration was evaluated in accordance with average rates prevailing in Israel in December 1998. Results: Ninety-two patients, 32 adolescents aged 12–18 years (mean ± SD 14.2 ± 1.9) and 60 adults aged 18–52 years (28.2 ± 3.2), were treated with intravenous acetylcysteine for acetaminophen overdose during the study period. Three patients (3.2%) developed adverse reactions: one adult presented with a maculopapular rash and pruritus, and two adolescents developed mild urticaria; no other adverse reactions were reported. All adverse reactions occurred during administration of the loading dose, 15–20 minutes after initiation of therapy. The reactions subsided a few hours after the acetylcysteine infusion was stopped and did not require antiallergy therapy. None of the three patients had a history of allergy. The 20-hour intravenous acetylcysteine protocol is approximately three times less expensive than the recommended oral regimen in terms of drug cost and length of hospitalization. Conclusions: Intravenous acetylcysteine is a relatively safe antidote for acetaminophen poisoning. The incidence rate of adverse reactions is low, and they are mild and easily controlled by termination of the infusion. We recommend intravenous acetylcysteine therapy, particularly for patients with vomiting caused by the acetaminophen overdose or by oral acetylcysteine therapy. The 20-hour intravenous acetylcysteine therapy has a cost-benefit advantage over oral therapy; however, the oral formulation is not approved by the FDA.

Organophosphate acetylcholine esterase inhibitor poisoning from a home-made shampoo

Organophosphate acetylcholine esterase inhibitor poisoning is a major health problem in children. We report an unusual cause of organophosphate acetylcholine esterase inhibitor poisoning. Two children were admitted to the pediatric intensive care unit due to organophosphate acetylcholine esterase inhibitor poisoning after exposure from a home-made shampoo that was used for the treatment of head lice. Owing to no obvious source of poisoning, the diagnosis of organophosphate acetylcholine esterase inhibitor poisoning in one of these patients was delayed. Both patients had an uneventful recovery. Organophosphate acetylcholine esterase inhibitor poisoning from home-made shampoo is possible. In cases where the mode of poisoning is unclear, direct questioning about the use of home-made shampoo is warranted, in these cases the skin and particularly the scalp should be rinsed thoroughly as soon as possible.

Snake bite by Cerastes vipera in children: report of two cases

Two children, ages 2 and 4 years, envenomed by the snake Cerastes vipera are presented. Both children suffered from local pain and swelling of the hand that spread up to the shoulder in the 2-year-old and up to the elbow in the 4-year-old. A hemorrhagic blister was noted on the bitten finger in the younger patient. Urinary retention, tachycardia, and a slight prolongation of prothrombin time was noted in the 2-year-old, whereas hypertension and fever were observed in the 4-year-old. In both cases, the swelling receded gradually and the patients were discharged from the hospital after several days without any complications and in a good condition.

Thyroid Involvement in Children With Familial Mediterranean Fever

was diagnosed in 101 children (55 girls and 46 boys) between 1975 and 1990 at the Department of Pediatrics, Soroka Medical Center, Beer-Sheva, Israel. All patients fulfilled the diagnostic criteria for FMF devised by Sohar et a1.9 The mean age at onset of the disease was 4.0 years (range: 0.5 years to 13 years). The disease started before the age of 5 years in 68% of patients. All the patients were Jews of Sephardic origin. Of the 101 children with FMF, 76 (46 girls and 30 boys, mean age 13.9 years) were 18 years of age or younger at the time of the study. In addition, 34 normal controls, matched for age and sex (20 girls and 14 boys, mean age 12.7 years),

Epidemiologic, Clinical, Laboratory, and Therapeutic Characteristics of Influenza A/h1n1 in Moslem Bedouin and Jewish Children Hospitalized in Southern Israel During 2009

A total of 739 (225 H1N1(+)) children with a diagnosis of acute respiratory infection were hospitalized during July to December 2009. The H1N1(+) children were compared with 225 randomly enrolled H1N1(−) children with an influenza-like illness. As compared with influenza-like illness patients, patients with 2009 influenza A/H1N1 were characterized by older age, more vomiting, less hypoxemia and wheezing, lower white blood cell counts, less neutrophilia, and severe lymphopenia.